174 related articles for article (PubMed ID: 10529002)
1. Changes of hypothalamic and plasma vasopressin in rats with deoxycorticosterone-acetate induced salt appetite.
Saravia FE; Grillo CA; Ferrini M; Roig P; Lima AE; de Kloet ER; De Nicola AF
J Steroid Biochem Mol Biol; 1999; 70(1-3):47-57. PubMed ID: 10529002
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of magnocellular vasopressin mRNA in rats with deoxycorticosterone-acetate induced salt appetite.
Grillo CA; Saravia F; Ferrini M; Piroli G; Roig P; García SI; de Kloet ER; De Nicola AF
Neuroendocrinology; 1998 Aug; 68(2):105-15. PubMed ID: 9705577
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats.
Pietranera L; Saravia F; Roig P; Lima A; De Nicola AF
Neuroendocrinology; 2004; 80(2):100-10. PubMed ID: 15475662
[TBL] [Abstract][Full Text] [Related]
4. Changes in Fos expression in various brain regions during deoxycorticosterone acetate treatment: relation to salt appetite, vasopressin mRNA and the mineralocorticoid receptor.
Pietranera L; Saravia FE; McEwen BS; Lucas LL; Johnson AK; De Nicola AF
Neuroendocrinology; 2001 Dec; 74(6):396-406. PubMed ID: 11752896
[TBL] [Abstract][Full Text] [Related]
5. Deoxycorticosterone stimulates the activity of nicotinamide adenine dinucleotide phosphate-diaphorase/nitric oxide synthase immunoreactivity in hypothalamic nuclei of rats.
Saravia FE; Pietranera L; Lima A; Roig P; Revsin Y; De Nicola AF
Neurosci Lett; 2002 Sep; 329(3):344-8. PubMed ID: 12183045
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv ANG II.
Roesch DM; Blackburn-Munro RE; Verbalis JG
Am J Physiol Regul Integr Comp Physiol; 2001 Jun; 280(6):R1853-64. PubMed ID: 11353692
[TBL] [Abstract][Full Text] [Related]
7. Salt appetite in salt-replete rats: involvement of mesolimbic structures in deoxycorticosterone-induced salt craving behavior.
Lucas LR; Pompei P; McEwen BS
Neuroendocrinology; 2000 Jun; 71(6):386-95. PubMed ID: 10878500
[TBL] [Abstract][Full Text] [Related]
8. Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin.
Bigalke JA; Gao H; Chen QH; Shan Z
Front Physiol; 2021; 12():641331. PubMed ID: 33633591
[TBL] [Abstract][Full Text] [Related]
9. Increased vasopressinergic activity following DOCA administration in the rat.
Chen YF; Lindheimer MD; Oparil S
Brain Res Bull; 1986 Jan; 16(1):93-8. PubMed ID: 3955390
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin gene transcripts in mineralocorticoid hypertension: an in situ study.
Ashen MD; Hartman RD; Barraclough CA; Petersen SL; Hamlyn JM
J Hypertens; 1992 Nov; 10(11):1317-26. PubMed ID: 1336517
[TBL] [Abstract][Full Text] [Related]
11. Effect of intracerebroventricular benzamil on cardiovascular and central autonomic responses to DOCA-salt treatment.
Abrams JM; Engeland WC; Osborn JW
Am J Physiol Regul Integr Comp Physiol; 2010 Dec; 299(6):R1500-10. PubMed ID: 20926762
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of hypothalamic neuronal nitric oxide synthase and vasopressin in salt-loaded Dahl rat.
Serino R; Ueta Y; Hanamiya M; Nomura M; Yamamoto Y; Yamaguchi KI; Nakashima Y; Yamashita H
Auton Neurosci; 2001 Mar; 87(2-3):225-35. PubMed ID: 11476283
[TBL] [Abstract][Full Text] [Related]
13. Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension.
Pitra S; Worker CJ; Feng Y; Stern JE
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H496-H504. PubMed ID: 31274353
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin mRNA regulation in individual hypothalamic nuclei: a northern and in situ hybridization analysis.
Sherman TG; McKelvy JF; Watson SJ
J Neurosci; 1986 Jun; 6(6):1685-94. PubMed ID: 3712004
[TBL] [Abstract][Full Text] [Related]
15. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
Okuno T; Winternitz SR; Lindheimer MD; Oparil S
Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
[TBL] [Abstract][Full Text] [Related]
16. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats.
Fujio T; Fujihara H; Shibata M; Yamada S; Onaka T; Tanaka K; Morita H; Dayanithi G; Kawata M; Murphy D; Ueta Y
J Neuroendocrinol; 2006 Oct; 18(10):776-85. PubMed ID: 16965296
[TBL] [Abstract][Full Text] [Related]
17. Increased activity of the orexin system in the paraventricular nucleus contributes to salt-sensitive hypertension.
Huber MJ; Fan Y; Jiang E; Zhu F; Larson RA; Yan J; Li N; Chen QH; Shan Z
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1075-H1086. PubMed ID: 28667055
[TBL] [Abstract][Full Text] [Related]
18. Effects of water deprivation on neurokinin B production by the arginine-vasopressin neurons of hypothalamic paraventricular and supraoptic nuclei.
Hatae T; Nakayama Y; Kawano H; Masuko S
Fukuoka Igaku Zasshi; 2001 Apr; 92(4):89-98. PubMed ID: 11411093
[TBL] [Abstract][Full Text] [Related]
19. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin- and oxytocin-immunoreactive nerve cells in the aging rat hypothalamus.
Lolova IS; Davidoff MS; Yakimoff NA
Acta Physiol Pharmacol Bulg; 1996; 22(1):7-16. PubMed ID: 8870838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
